Navigation Links
Resverlogix Phase 1b/2a Study Meets Primary Endpoint
Date:8/25/2009

family reasons. Due to Mr. McNeill's important contributions to the ongoing corporate development of Resverlogix the Board of Directors in conjunction with Mr. McNeill have agreed to nominate Mr. McNeill as a corporate director at the upcoming October 15th, 2009 Annual General Meeting. Mr. McNeill's promotion to the Board of Directors is a welcome addition that will allow the corporation to continue to benefit from Mr. McNeill's in depth knowledge of Resverlogix and its upcoming corporate development plans.

Resverlogix has recently published one paper in a chemistry publication, Tetrahedron 2009, 65, 6932. Resverlogix will continue to publish a series of research papers demonstrating Resverlogix's understanding of the ability to induce the expression of the Apo A1 gene by small molecules.

Two new important papers have been added to the Resverlogix corporate web site. The first is a detailed White Paper describing Resverlogix understanding of the Reverse Cholesterol Transport system and the Company's targeted goals of reducing the Percent Atheroma Volume (PAV) plaque build up in the arterial wall. The second paper is an abstract of a recently completed Pharmacoeconomics study showing the potential economic impact of being able to reduce the PAV as it relates to the impact on the overburdened US health system. These articles can be found at http://www.resverlogix.com/media/fact_sheets.html.

About RVX-208

RVX-208, a novel small molecule therapeutic that facilitates endogenous ApoA-I production, is positioned to be one of the most promising emerging drugs in the treatment of atherosclerosis. To the Company's knowledge RVX-208 is the only novel small molecule that is specifically designed to increase ApoA-I production and thereby raise HDL levels thus enhancing HDL functionality to augment reverse cholesterol transpor
'/>"/>

SOURCE Resverlogix Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Resverlogixs Success in Inflammation Program Results in 2 Patents Filed
2. Resverlogix Provides Quarterly Update
3. Resverlogix Board of Directors Update
4. Resverlogix Advances to Second Arm of Phase 1b/2a Clinical Trial
5. Resverlogix Announces Closing of Debt Redemption
6. Resverlogix Eliminates Sixty Percent of Remaining Debt
7. Resverlogix Issues a Management Statement
8. Resverlogix Board of Directors Update
9. Resverlogix Notice of Conference Call & Webcast
10. Jan Gray Joins Resverlogix Board of Directors
11. Resverlogixs Lead Drug Featured in Key Scientific Publication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Sept. 16, 2014 In preparation for VARTECH ... -based cybersecurity company focused on authentication and SSO announced ... the ability to generate a OTP through the presentation ... pioneer of user-based RFID authentication, 2FA,s solutions have leveraged ... for many years. RFID authentication is broadly deployed in ...
(Date:9/16/2014)... Australia (PRWEB) September 16, 2014 RENU 28, ... Signaling molecules, became available for purchase in Australia and ... a nationwide tour beginning September 16th. The tour will make ... the 17th, Bundaberg on the 18th, Sydney on the 20th, ... market in Australia and New Zealand and to educate people ...
(Date:9/15/2014)... States (PRWEB) September 16, 2014 ... Cancer Vaccines, and Adoptive T-cell Therapies is a ... report focuses on the three principal types of ... research and development in cancer immunotherapy (which is ... Therapeutic anticancer vaccines and Adoptive cellular immunotherapy. ...
(Date:9/15/2014)... University have developed a technique for controlling the surface ... opening the door to a new generation of reconfigurable ... on the fact that the oxide "skin" of the ... acts as a surfactant, lowering the surface tension between ... used a liquid metal alloy of gallium and indium. ...
Breaking Biology Technology:2FA, Inc. Announces RFID-based One-Time Password (OTP) Authentication 2Global Wellness Company Hosts ASEA Australia Tour September 16-22 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 2Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 3Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 4Cancer Immunotherapy Market: Immune Checkpoint Inhibitors, Cancer Vaccines, and Adoptive T-cell Therapies 5Researchers control surface tension to manipulate liquid metals 2
... SOUTH SAN FRANCISCO, Calif., June 11 iZumi ... industrialization of induced pluripotent stem cell (iPS) technology ... cellular reprogramming and directed differentiation of patient cells, ... Ph.D., to the company,s board of directors and ...
... Calif., June 11 STAAR Surgical Company (Nasdaq: ... of minimally invasive ophthalmic products, today announced that the ... System for use with the Affinity(TM) Collamer(R) Three-Piece NTIOL ... Epiphany will usher in a new era of insertion ...
... WALTHAM, Mass., June 11 Repligen Corporation (Nasdaq: ... fiscal year 2009, ended March 31, 2009. Total revenue ... of $19,296,000 for fiscal year 2008 ended March 31, 2008, ... the year was comprised of Protein A product revenue, and ...
Cached Biology Technology:iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board 2iZumi Bio Appoints Dr. Corey Goodman to Board of Directors and Scientific Advisory Board 3STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 2STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System 3Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 2Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 3Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 4Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 5Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 6Repligen Reports Fourth Quarter and Fiscal Year 2009 Financial Results 7
(Date:9/16/2014)... make ethical choices such as buying clothing not made ... coffee, and bringing their own bags when they go ... Journal of Consumer Research , ethical consumption is motivated ... about unethical practices into action. , "Advocates of ethical ... human costs of the products they choose, but unfortunately ...
(Date:9/16/2014)... N.C. , Sept. 16, 2014  Valencell, Inc., ... been chosen as one of 18 "Showcase Companies" representing ... businesses at the annual CED Tech Venture Conference on ... Convention Center in Raleigh, North ... will lead a discussion during the "Digital Health ...
(Date:9/16/2014)... a season of bounty. Fungi of dizzying variety erupt ... in search of elusive but delectable wild mushrooms. Part ... treasure hunt, and their mysterious not-quite-meat, not-quite-vegetable qualities that ... which you are eating known to science? , The ... although some estimates range up to 10 million species, ...
Breaking Biology News(10 mins):Why are consumers willing to spend more money on ethical products? 2Valencell, Inc. Selected as 'Showcase Company' at CED Tech Venture Conference 2014 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 2What's for dinner? Rapidly identifying undescribed species in a commercial fungi packet 3
... disease are increasingly becoming resistant to synthetic insecticides. Now ... Complementary and Alternative Medicine suggests that the berries of ... have potential for keeping mosquitoes at bay. S. ... for its medicinal properties and commonly used as ...
... Southern Research Station (SRS), Iowa State University, and the ... of a fungus responsible for the wilt of redbay ... Florida. In the February issue of Plant Disease, ... results from their assessment of the fungus, the beetle ...
... but the microscopic animals called bdelloid rotifers seem to get ... have done so over millions of years of evolution, resulting ... the usual drawback of asexuality extinction and the ... finding out how. In two related papers published ...
Cached Biology News:Ayurvedic nightshade deadly for dengue mosquito 2Laurel wilt of redbay and sassafras: Will avocados be next? 2Is DNA repair a substitute for sex? 2Is DNA repair a substitute for sex? 3
... for use as a wash buffer for Michels ... is useful for transportation of specimens (such as ... Samples may remain in Transport Fluid for ... Michels Transport Fluid is not a fixative and ...
... use with 96- or 384-well PCR plates Dimples ... location on 96-tube plates End tabs on Thermo-Mat™ ... plate* Efficient sealing is achieved with either Thermo-Mat™ ... or clip-down hot lid thermal cyclers Fully autoclavable ...
... TUNEL-based assay kit provides complete components including ... detection of DNA fragmentation in cultured cells ... in the procedure provides greater sensitivity than ... analyzed by flow cytometry. The kit works ...
... Buffer is a unique alternative to ... (TRIS acetate-EDTA) electrophoresis buffers. Bionic Buffer ... rapid running times, and high-resolution band ... gel electrophoresis after dilution to working ...
Biology Products: